Latest Invex Therapeutics (ASX:IXC) News
Page 2
Page 2 of 3
Healthcare Wrap - Week 4 (19 Jan -> 23 Jan) 2026
25 Jan 2026
Invex Therapeutics Advances Alzheimer’s Research Amid Board Shakeup and $4.5M Cash Reserve
22 Jan 2026
Invex Therapeutics Resumes Trading After Key Board Appointments
10 Nov 2025
Invex Therapeutics Refreshes Board and Leadership Amid Strategic Reset
10 Nov 2025
Invex Therapeutics Suspended from ASX Over Board Shortfall
7 Nov 2025
Invex Therapeutics Halts Two Neurological Deals Amid Board Turmoil
3 Oct 2025
Invex Therapeutics Resumes Trading After Major Acquisition Reveal
30 Sept 2025
Invex Therapeutics Halts Acquisition Talks Amid Boardroom Turmoil
30 Sept 2025
Invex Therapeutics Halts Acquisition Amid Boardroom Turmoil
30 Sept 2025
Invex Therapeutics Halts Trading Ahead of Major Acquisition Reveal
25 Sept 2025
Invex Therapeutics Narrows Loss, Unveils Alzheimer’s Breakthrough in Exenatide Research
11 Aug 2025
Invex Therapeutics Expands Alzheimer’s Research and Secures Orphan Drug Renewals
23 July 2025